Atyr Pharma Inc (ATYR)

R&D Expense Growth

-7.78%

Quarterly · Period ending:

ATYR logo

ATYR R&D Expense Growth

Latest reported-7.78%
ATYR Quarterly R&D Growth (QoQ) (0.00% → -7.78%)
High-resolution chart · PNG

ATYR r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Atyr Pharma Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-7.7764%
-32.8161%
-50.7863%
43.8508%
30.2184%
-3.3857%
-17.4174%
5.9687%
4.557%
4.7746%
23.6069%
4.8679%
4.9152%
-37.0959%
51.1098%
8.0131%
2.6866%
49.3871%
15.9011%
-32.8805%
69.5084%
-3.874%
1.7764%
5.8473%
20.6029%
0.7242%
-5.5014%
14.6349%
-0.9268%
-5.7481%
-15.5402%
-35.1943%
5.4309%
15.8192%
-25.5573%
-15.285%
-8.518%
0.6562%
-12.0346%
-8.0658%
-5.775%
-5.2881%
63.7162%
3.1592%
13.7874%
51.8774%
-1.5646%
21.2205%
-17.0921%
6.79%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.